News | January 20, 2015

University of Tennessee Engineering Research Offers Hope for Heart Valve Patients

Teams working to create calcification-proof tissue-engineered heart valves

Tennessee, Knoxville, heart valve, tissue engineered, calcification proof

January 20, 2015 — There could soon be new hope for those facing one of humanity's biggest health issues, thanks to research from the University of Tennessee Knoxville College of Engineering. 

Cardiovascular diseases are the world's number one cause of death, with some estimates indicating that as many as one-third of the planet's deaths in a given year are attributable to some form of the disease. 

While heart valve disease is only one of many afflictions falling under that heading, its widespread impact — affecting up to 30 percent of the elderly population in developed countries alone — makes it a key component of the overall problem of heart-related ailments.

Zannatul Ferdous, an assistant professor in UT's Department of Mechanical, Aerospace, and Biomedical Engineering, leads a research team addressing the issue, thanks in part to a BRIGE — Broadening Participation Research Initiation Grants in Engineering — grant from the National Science Foundation.

"Currently, the treatment option for valve disease is mainly end-stage replacement or repair surgeries, and no early treatment or detection options exist," said Ferdous. "The goal of our lab is to understand these diseases and develop alternate treatment options such as functional tissue-engineered heart valves."

One of the main issues with heart valves that the group is focusing on is what is known as calcification, a process where calcium deposits build up on the valves, eventually restricting the flow of blood through the heart. 

By studying the root causes of calcification and constructing new heart valves through tissue engineering — using cells to construct organic human tissue — Ferdous and her group aim to eventually develop calcification-proof valves. 

“We are tackling calcification head-on, looking at risk factors from everything like age and gender to chemical factors and cell characteristics," said Ferdous. "At the same time, we are developing custom devices that will allow us to truly mimic all the forces at play in the heart.”

For more information: www.mabe.utk.edu

Related Content

Abbott Tricuspid Valve Repair System Reduces Tricuspid Regurgitation at 30 Days
News | Heart Valve Technology | June 11, 2019
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE...
DSM and SAT Partnering to Develop Next-Generation, Cost-Effective Heart Valve
News | Heart Valve Technology | June 04, 2019
Royal DSM recently announced a collaboration with Strait Access Technologies (SAT), to develop the world’s first...

The MitraClip is one example of a transcatheter mitral valve repair or replacement (TMVR) device used in the structural heart repair program at Henry Ford Hospital.

Podcast | Heart Valve Technology | May 31, 2019
Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of
Illustration showing the catheter steps for the LAMPOON procedure designed to prevent left ventricular outflow tract (LVOT) obstruction . From Dr. Jaffar M. Khan and the Laboratory of Cardiovascular Intervention, led by Dr. Robert J. Lederman.

Figure 1: Illustration showing the catheter steps for the LAMPOON procedure. From Dr. Jaffar M. Khan and the Laboratory of Cardiovascular Intervention, led by Dr. Robert J. Lederman.

Feature | Heart Valve Technology | May 22, 2019
Researchers at the National, Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH
Edwards Announces Research Milestones for Pascal Transcatheter Mitral Valve Program
News | Heart Valve Technology | May 22, 2019
Edwards Lifesciences Corp. announced strategic clinical and regulatory milestones for its Edwards Pascal transcatheter...
Videos | Heart Valve Technology | May 20, 2019
A demonstration of how to calculate the neo-left ventricular outflow tract (neo-LVOT) on CT imaging for a transcathet
Study Finds TAVR Can Be Considered for Patients in All Surgical Risk Classes
News | Heart Valve Technology | May 08, 2019
Transcatheter aortic valve replacement (TAVR) has been studied as an alternative to surgical aortic valve replacement...
Boston Scientific Receives FDA Approval for Lotus Edge Aortic Valve System
Feature | Heart Valve Technology | April 23, 2019 | Dave Fornell, Editor
Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) approval for the Lotus Edge...
New Consensus Document Explores Optimized Care for Valvular Heart Disease Patients
News | Heart Valve Technology | April 22, 2019
April 22, 2019 — Five cardiovascular professional societies released a new consensus document on optimizing care for
Mick Jagger Recovering After TAVR Procedure
News | Heart Valve Technology | April 08, 2019 | Jeff Zagoudis, Associate Editor
Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic valve valve...
Overlay Init